Provided by Tiger Trade Technology Pte. Ltd.

SAP SE ADRhedged

38.28
-0.4598-1.19%
Post-market: 38.460.1817+0.47%16:10 EDT
Volume:332
Turnover:12.79K
Market Cap:765.60K
PE:- -
High:38.46
Open:38.46
Low:38.28
Close:38.74
52wk High:51.57
52wk Low:27.49
Shares:20.00K
Float Shares:20.00K
Volume Ratio:0.51
T/O Rate:1.66%
Dividend:1.19
Dividend Rate:3.11%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (ANL)

TIPRANKS
·
Aug 15

New York Closing Stocks

Dow Jones
·
Aug 15

Jianzhi Education Technology Launches $5.4 Million ADS Offering to Bolster Operations

TIPRANKS
·
Aug 14

Press Release: Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update

Dow Jones
·
Aug 14

Mizuho Securities Remains a Buy on Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
Aug 14

Anheuser-Busch InBev S.A. ADR Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 14

Ascentage Pharma Corrects Timing for August 19, 2026 Interim Results Webcast

TIPRANKS
·
Aug 13

Copel Board Approves R$706 Million Interest on Equity and 2025 Form 20-F Filing

TIPRANKS
·
Aug 13

Asian Companies Raise $28 Billion via ADRs in 2024, Marking a Six-Year High, as AI Boom and Valuation Gaps Drive Listings

Stock News
·
Aug 13

Anheuser-Busch InBev S.A. ADR Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

New York Closing Stocks

Dow Jones
·
Aug 13

Stocks Ex-Dividend August 14

Dow Jones
·
Aug 13

Haleon’s New Gum‑Health Toothpaste Trial: What Investors Should Watch

TIPRANKS
·
Aug 13

Cantor Fitzgerald Reaffirms Their Buy Rating on Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
Aug 12

Kaspi.kz Posts Strong H1 2026 Revenue Growth as Costs Hold Profit Flat

TIPRANKS
·
Aug 12

Yi Chen Raises Approval Odds and Lifts Tinlarebant-Focused 12‑Month Price Target to $214 While Reiterating Buy Rating

TIPRANKS
·
Aug 12

NYSE Net Change Percentage Gainers & Losers

Dow Jones
·
Aug 12

NYSE Most Active Issues

Dow Jones
·
Aug 12

Anheuser-Busch InBev S.A. ADR Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease

TIPRANKS
·
Aug 12